Texture Analysis of CT Images in Head and Neck Tumors Differentiation

Objective : to determine the diagnostic significance of computed tomography texture analysis (CTTA) in differentiating head and neck tumors. Material and methods . The study included 118 patients aged from 4 to 80 years with a verified diagnosis of benign and malignant (37 and 81, respectively) head...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vestnik rentgenologii i radiologii 2022-10, Vol.103 (4-6), p.28-35
Hauptverfasser: Khodjibekova, Yu. M., Khodjibekov, M. Kh, Akhmedov, B. R., Pattokhov, A. Sh, Nigmatdjanov, A. S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective : to determine the diagnostic significance of computed tomography texture analysis (CTTA) in differentiating head and neck tumors. Material and methods . The study included 118 patients aged from 4 to 80 years with a verified diagnosis of benign and malignant (37 and 81, respectively) head and neck tumors. CTTA was performed using the LIFEx program, version 6.30. Thirty eight (38) texture indices extracted from routine CT images were tested by regression analysis with creation of logistic texture models with associations of four indices as independent predictors. Results . The possibility of using derived models – probability textural indices for benign and malignant tumors differentiation was established: area under ROC-curve (AUC) 0.854 ± 0.035 (p < 0.001); for differentiation of locally spread from locally limited tumors: AUC 0.840 ± 0.049 (p < 0.001); for differentiation of moderately, poorly, and undifferentiated cancer (G2, G3, G4) from well-differentiated (G1) head and neck cancer: AUC 0.826 ± 0.085 (p < 0.001). Conclusion . CT images texture analysis allows to make non-invasive prognosis of benign or malignant nature of a visualized head and neck tumor, as well as to determine the extent and degree of tumor malignancy.
ISSN:0042-4676
2619-0478
DOI:10.20862/0042-4676-2022-103-4-6-28-35